Common Viruses Tied to Higher Risk of Major Cardiovascular Events in Weeks After Infection

COVID, flu, hepatitis C, and shingles infection all were tied to dramatically higher rates of cardiovascular events immediately following infection.

A meta-analysis of 155 observational studies “ties influenza, COVID-19, hepatitis C, and herpes zoster (shingles) to a dramatically higher risk of major cardiovascular events such as heart attack and stroke in the weeks after infection, and viruses that linger in the body (eg, HIV) can raise long-term risk.” CIDRAP has the news.

The 155 studies were published from 1997 to July 2024. Self-controlled case studies “tied flu to a fourfold elevated risk of heart attack…and a fivefold higher risk of stroke during the first 1 month, and cohort studies suggested a higher risk of coronary heart disease (CHD) with hepatitis C infection and stroke.” Also, “HIV was consistently linked to a higher risk of CHD and stroke, as was SARS-CoV-2.” Shingles was also associated with elevated risk that “translates into a large number of excess cases of cardiovascular disease at the population level.”

The study authors wrote that “viral infections trigger the immune system to release substances that lead to inflammation and increase the risk of blood clots, processes that may persist long after initial infection and raise the risk of heart attack and stroke.”

The team also called for “more research on the possible relationship between the risk of heart disease risk and cytomegalovirus, herpes simplex 1 (the virus that causes cold sores), hepatitis A, respiratory syncytial virus (RSV), chikungunya, dengue (a mosquito-borne virus), and human papillomavirus (which can cause cervical and other cancers).”

About the Author

Matt MacKenzie

Matt MacKenzie

Associate Editor

Matt MacKenzie is Senior Staff Writer and Associate Editor of Healthcare Purchasing News (HPN), where he leads daily news coverage and contributes in-depth features on healthcare supply chain, sterile processing, infection prevention and clinical operations. Through industry reporting and expert interviews, he examines the trends, technologies and operational challenges shaping healthcare purchasing and patient care. 

Sign up for our eNewsletters
Get the latest news and updates